Bristol Myers Squibb Co. (BMY)
66.79
+0.21
(+0.32%)
USD |
NYSE |
Aug 31, 16:00
66.94
+0.15
(+0.22%)
After-Hours: 20:00
Bristol Myers Squibb Cash from Operations (TTM) : 12.78B for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.78B |
| March 31, 2026 | 13.31B |
| December 31, 2025 | 14.16B |
| September 30, 2025 | 16.62B |
| June 30, 2025 | 15.90B |
| March 31, 2025 | 14.31B |
| December 31, 2024 | 15.19B |
| September 30, 2024 | 15.00B |
| June 30, 2024 | 14.16B |
| March 31, 2024 | 13.72B |
| December 31, 2023 | 13.86B |
| September 30, 2023 | 12.91B |
| June 30, 2023 | 11.85B |
| March 31, 2023 | 12.22B |
| December 31, 2022 | 13.07B |
| September 30, 2022 | 13.82B |
| June 30, 2022 | 15.40B |
| March 31, 2022 | 16.20B |
| December 31, 2021 | 16.21B |
| September 30, 2021 | 15.82B |
| June 30, 2021 | 12.77B |
| March 31, 2021 | 13.98B |
| December 31, 2020 | 14.05B |
| September 30, 2020 | 12.42B |
| June 30, 2020 | 12.76B |
| Date | Value |
|---|---|
| March 31, 2020 | 10.57B |
| December 31, 2019 | 8.067B |
| September 30, 2019 | 8.458B |
| June 30, 2019 | 7.181B |
| March 31, 2019 | 6.155B |
| December 31, 2018 | 5.94B |
| September 30, 2018 | 4.628B |
| June 30, 2018 | 5.062B |
| March 31, 2018 | 5.589B |
| December 31, 2017 | 5.275B |
| September 30, 2017 | 5.586B |
| June 30, 2017 | 5.27B |
| March 31, 2017 | 4.097B |
| December 31, 2016 | 2.85B |
| September 30, 2016 | 2.033B |
| June 30, 2016 | 1.16B |
| March 31, 2016 | 820.00M |
| December 31, 2015 | 1.832B |
| September 30, 2015 | 1.793B |
| June 30, 2015 | 2.172B |
| March 31, 2015 | 3.157B |
| December 31, 2014 | 3.148B |
| September 30, 2014 | 3.986B |
| June 30, 2014 | 4.136B |
| March 31, 2014 | 4.59B |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Johnson & Johnson | 27.61B |
| Eli Lilly & Co. | 28.08B |
| Merck & Co., Inc. | 19.97B |
| Pfizer Inc. | 13.40B |
| AstraZeneca PLC | 14.54B |